Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
Condition:   Adv Solid Malig – H&N SCC, ATM Pro / Def NSCLC, Gastric & Breast Cancer
Interventions:   Drug: Administration of ceralasertib in combination with carboplatin;   Drug: Administration of ceralasertib;   Drug: Administration of ceralasertib in combination with olaparib;   Drug: Administation of ceralasertib in combination with durvalumab
Sponsor:   AstraZeneca
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 25, 2020 / by / in
Comments